In a clinical trial at the German Center for Infection Research (DZIF), leukaemia patients are being administered specially purified immune cells, so-called memory T cells, for the first time after a
A potential lifesaver lies unrecognized in the human body: Scientists at the University of Tübingen and the German Center for Infection Research (DZIF) have discovered that Staphylococcus lugdunensis
Hopes for tuberculosis treatment have been raised by an international study in which DZIF scientists from the Research Center Borstel were also involved. Resistance to pyrazinamide und
A team of researchers from the Heinrich Pette Institute and the USA have succeeded in identifying a protein called HLA-F which functions as the ligand of an activating natural killer cell receptor
In June, the World Health Organisation (WHO) decided that the Olympic Games in Rio de Janeiro can take place despite the Zika virus. The risk of a further international spread is low. The virus is
DZIF scientists from Lübeck have succeeded in uncovering the three dimensional structure of a key enzyme in the Zika virus. With this, they have laid the basis for developing antiviral agents. The
An international team of scientists has had unexpected success in treating tuberculosis with a ß-lactam antibiotic that is approved for other indications. DZIF scientists from the Research Center
At the German Center for Infection Research (DZIF), research projects can be initiated within a week via a fast track procedure if required. This is especially relevant to emerging infections and
Providing a new paradigm to hepatitis B understanding, researchers at the German Cancer Research Center (DKFZ), the Heidelberg University Hospital and the German Center for Infection Research (DZIF)
